Panbela Therapeutics Inc (PBLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,439 | -14,260 | -7,120 | -25,263 | -18,789 |
| Accounts payable and accrued liabilities | 798 | 4,578 | -957 | 7,060 | 4,370 |
| Other Working Capital | 9,095 | 4,472 | -2,409 | -647 | -3,851 |
| Other Operating Activity | -947 | -5,163 | 1,094 | -6,399 | -3,899 |
| Operating Cash Flow | $-12,493 | $-10,373 | $-9,392 | $-25,249 | $-22,169 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 775 | 775 | N/A | 400 | 400 |
| Investing Cash Flow | $775 | $775 | $N/A | $400 | $400 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,200 | N/A | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | N/A | -1,650 | N/A |
| Common Stock Issued | 8,082 | 8,082 | 8,082 | 27,802 | 23,052 |
| Other Financing Activity | -1,000 | -1,000 | -1,000 | -10 | -1,659 |
| Financing Cash Flow | $9,282 | $7,082 | $7,082 | $26,142 | $21,393 |
| Exchange Rate Effect | N/A | -3 | -6 | N/A | -2 |
| Beginning Cash Position | 2,578 | 2,578 | 2,578 | 1,285 | 1,285 |
| End Cash Position | 142 | 59 | 262 | 2,578 | 907 |
| Net Cash Flow | $-2,436 | $-2,519 | $-2,316 | $1,293 | $-378 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,493 | -10,373 | -9,392 | -25,249 | -22,169 |
| Free Cash Flow | -12,493 | -10,373 | -9,392 | -25,249 | -22,169 |